Oral cancer diagnosis via a ferrocenylnaphthalene diimide-based electrochemical telomerase assay

Clinical Chemistry

Volumn 59, Issue 1, 2013, Pages 289-295

  Mori, Kumiko ^a   Sato, Shinobu ^b   Kodama, Masaaki ^a   Habu, Manabu ^a   Takahashi, Osamu ^a   Nishihara, Tatsuji ^a   Tominaga, Kazuhiro ^a   Takenaka, Shigeori ^b  

^a KYUSHU DENTAL COLLEGE   (Japan)

^b KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FERROCENYLNAPHTHALENE DIIMIDE; NAPHTHALENE DERIVATIVE; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCHEMICAL ANALYSIS; ELECTROCHEMICAL TELOMERASE ASSAY; ELECTRODE; ENZYME ASSAY; ENZYME IMMOBILIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR PROBE; MOUTH SQUAMOUS CELL CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR BIOPSY;

CELL LINE, TUMOR; ELECTROCHEMICAL TECHNIQUES; FERROUS COMPOUNDS; HUMANS; IMIDES; MOUTH NEOPLASMS; TELOMERASE;

EID: 84872009549     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.191569     Document Type: Article

References (15)

1. Harrington L. Biochemical aspects of telomerase function. Cancer Lett 2003;194:139-54.
2. Hiyama E, Hiyama K. Telomerase as tumor marker. Cancer Lett 2003;194:221-33.
3. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
4. Sato S, Kondo H, Nojima T, Takenaka S. Electrochemical telomerase assay with ferrocenylnaphthalene diimide as a tetraplex DNA-specific binder. Anal Chem 2005;77:7304-9.
5. Kodama T, Ikeda E, Okada A, Ohtsuka T, Shimoda M, Shiomi T, Yoshida K, et al. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of HB-EGF. Am J Pathol 2004;165:1743-53.
6. Ohtsuka K, Endo H, Morimoto K, Vuong BN, Ogawa H, Imai K, Takenaka S. Detection of antibody to avian influenza virus with electrochemical immunoassay (eELISA). Anal Sci 2008;24:1619-22.
7. Sato S, Takenaka S. Linker effect of ferrocenylnaphthalene diimide ligands in the interaction with double stranded DNA. J Organomet Chem 2008;693:1177-85.
8. Fujimoto R, Kamata N, Yokoyama K, Ueda N, Satomura K, Hayashi E, Nagayama M. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol 2001; 37:132-40.
9. Murakami J, Asaumi J, Kawai N, Tsujigiwa H, Yanagi Y, Nagatsuka, H, et al. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. Cancer Chemother Pharmacol 2005;56:22-8.
10. Sato S, Takenaka S. PCR-free telomerase assay using chronocoulometry coupled with hexaammineruthenium(III) chloride. Anal Chem 2012;84:1772-5.
11. Rant U, Arinaga K, Fujita S, Yokoyama N, Abstreiter G, Tornow M. Dynamic electrical switching of DNA layers on a metal surface. Nano Lett 2004;4:2441-5.
12. Rasmussen RP, Morrison TB, Herrmann MG, Wittwer CT. Quantitative PCR by continuous fluorescence monitoring of a double strand DNA specific binding dye. Biochemica 1998;2:8-11.
13. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
14. Broccoli D, Young JW, Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995;92:9082-6.
15. Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Alberto C, Bevilacqua, G. Clinical utility of telomerase in cancer. Clin Cancer Res 1999;5:2077-81.